Dow Agrosciences wanted to see if
engineered zinc finger nucleases could speed up genetic engineering.
Eventually, the team of Dow and Sangamo scientists showed that it could
engineer zinc finger nucleases that gave a two - for - one deal.
Not exact matches
By using
engineered zinc -
finger nucleases (ZFNs) designed to target an integrated reporter and two endogenous rat genes, Immunoglobulin M (IgM) and Rab38, we demonstrate that a single injection of DNA or messenger RNA encoding ZFNs into the one - cell rat embryo leads to a high frequency of animals carrying 25 to 100 % disruption at the target locus.
Talk of curing AIDS made front - page news last year, in part due to an astonishing new gene - editing technology: lab -
engineered proteins called
zinc finger nucleases.
Here we describe
engineering a pair of
zinc finger nucleases that, when introduced into human T cells, efficiently disrupt cxcr4 by cleavage and error - prone non-homologous DNA end - joining.
Previously we
engineered zinc -
finger nucleases (ZFNs) to specifically disrupt the CCR5 gene in primary human T cells, the predominant cell type infected and killed by HIV.
Working with proteins called
zinc finger nucleases and TALENs, Zhang attempted to edit the genomes of mammalian cells with a view to
engineering them.
With the genome
engineering revolution came epigenome -
engineering tools -
zinc finger nucleases and TALENs fused to epigenetic modifiers enabled epigenetic modifications at a user - specified locus.